Phase 1 Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 701 in Subjects With Multiple Myeloma

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
Phase 1 Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 701 in Subjects With Multiple Myeloma

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.